Business Development & Licensing Course For Pharma & Biotech
With Dr Carlos Velez
Course Details
THE CONTENT
For many pharma companies, business development (BD) is the most important source of new products. Yet, too often, BD efforts underperform due to a lack of strategic alignment and limited understanding across the organisation of how the full licensing process works.
This course provides a clear and practical overview of the BD&L process in the pharma-biotech industry. By connecting the dots between strategy, process, and execution, it equips you with the essential foundation to understand the full BD&L process – from sourcing and evaluating opportunities to valuation, term sheets, and the fundamentals of negotiation – all within the context of pharma-biotech business development.
If you want to build the skills and confidence to actively contribute to successful BD&L activities, this course is the perfect investment!
Very nice overview of everything that is part of BD and Licensing! There is a variety of topics covered, and the teaching qualities of Carlos Velez were amazing. The organisation of the course was great.
Daiichi Sankyo Europe
Joris Komen, Senior Medical Manager New Products - The Netherlands - September 2025
THE EXPERT
Dr Carlos Velez is a seasoned expert in pharma and biotech business development and licensing.
Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in in- and out-licensing of prescription and non-prescription product candidates and commercial products across multiple therapeutic areas and markets.
Over 10 years in senior business development roles at Penwest Pharmaceuticals, Lantic Therapeutics, Forest Labs, and Genencor (now Danisco).
Author of Partnering for Growth – Business Development and Licensing in Pharma and Biotech (2025), a comprehensive guide reflecting his extensive industry insights.
Highly experienced trainer and consultant who is consistently praised by participants for his excellent didactic approach and his ability to draw from his vast experience in business development and licensing.
To get a flavour of Carlos’ expertise and teaching style, watch this recent educational webinar:
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This introductory course is designed for:
Mid- to senior-level executives in pharma and biotech companies with limited formal training in BD&L but whose role increasingly involves licensing activities.
Junior- to mid-level managers contributing to the BD&L process in the headquarters of midsize and large pharma companies (e.g. technology assessment, business intelligence) who need a better understanding of the full licensing process in a business development context.
Managers in local marketing organisations with responsibility for business development and licensing in national markets will also benefit, but they should be aware that the course content is geared towards international BD&L responsibilities.
Executives working in generics companies should be aware that the content of this course concentrates on licensing deals involving branded pharmaceuticals.
This course is very helpful for understanding the basics of BD, including calculations and the environment of out- and in-licensing. It’s a great first step into the world of BD for someone less familiar with the field, and it helps participants decide where to further develop their skills (financials, negotiation, etc.). The case study provides an excellent summary of the two days.
Roche
Carole Mainguet, External Collaboration Lead - Switzerland - September 2025
The role of the BD&L function and partnering models for corporate growth.
Key success factors and tips for the planning and execution of both the in- and out-licensing process.
What you need to know about patents and intellectual property.
Overview of forecasting and valuation tools, methods and approaches.
Introduction to term sheets, negotiation, closing the deal and managing the alliance.
Where and how AI can be used along the BD&L process.
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
Day 1
| Welcome & Audience Expectations (~30 min) |
| Introduction to Business Development in Pharma/Biotech (~1 h) |
|
| Out-Licensing: Planning and Execution (~1 h) |
|
| Lunch Break |
| Workshop #1: AI-Assisted Out-Licensing (~45 min) |
|
| In-Licensing: Planning & Execution (~1 h 15 min) |
|
| Valuation of Drug Candidates – Part I (~1 h 45 min) |
|
Day 2
| Day One Questions and Comments (~15 min) |
| Patents and Intellectual Property (~45 min) |
|
| Valuation of Drug Candidates – Part II (~1 h 15 min) |
|
| Workshop #2: AI-Assisted In-Licensing (~45 min) |
|
| Lunch Break |
| Term Sheets and Contracts (~1 h) |
|
| Special Situations (~1 h) |
|
| Negotiation & Alliance Management (~45 min) |
|
| Workshop #3 – AI-Assisted Licensing (~1 h) |
|
| Q&A and Closing (~15 min) |
UPCOMING DATES & FORMATS - FEES
11-12 June 2026
Live online
Early bird € 2 670
(until 08/05/2026)
(Full fee € 2 870)
1-2 October 2026
Brussels
Early bird € 2 970
(until 14/08/2026)
(Full fee € 3 370)
10-11 December 2026
Live online
Early bird € 2 670
(until 06/11/2026)
(Full fee € 2 870)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
For live online courses:
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
For face-to-face courses:
Access to a highly interactive, small-group course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
Opportunities for networking and informal discussions during coffee/tea breaks and lunch
A group dinner in a nearby restaurant on the evening of day 1
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The Business Development & Licensing Course provided a valuable, structured approach to running BD tasks effectively. The exchange with participants from different backgrounds and with different interests enhanced the discussions and resulted in valuable takeaways for future daily assessment tasks. I also appreciated the overview of useful tools in this context and the perspective on AI. Many thanks, Carlos!
Daiichi Sankyo
Andrea Bilgeri, Director Market Access - Germany - March 2026
A great experience attending the Business Development & Licensing Course. It was a valuable opportunity to take a step back and reflect on how to approach BD activities in a more structured and strategic way. The exchange with professionals from different backgrounds made the discussions especially enriching and brought practical ideas to apply in our day-to-day work. Thank you, Carlos, for such an engaging course!
Medichem
Helena Huguet, Business Development Manager - Spain - March 2026
Dr Carlos Velez is a very good and experienced teacher who provides great examples and a clear structure for focusing on business development. I would highly recommend this course!
LTS Lohmann Therapie-Systeme
Christine Lohmann, Business Development Europe - Germany - March 2026
If you are interested in discovering or learning more about licensing, I recommend attending the CELforPharma Business Development & Licensing Course. It is led by an experienced and pragmatic trainer in a relaxed and interactive atmosphere.
OXB
Alain Rachon, Senior Director Business Development & Licensing - France - March 2026
Great course with a clear overview of the business development and licensing process. Recommended if you need to learn the basics.
Chiesi
Giorgia Iegiani, Competitive Intelligence Specialist - Italy - March 2026
A very helpful course for taking your first steps into BD. Carlos is an expert in the field and shares great tips and tricks.
Etherna Immunotherapies
Bram Bogaert, Business Development Manager - Belgium - March 2026
A very good training to get an overall overview of BD & Licensing. The trainer is highly skilled and clear in their explanations, and brings substantial practical experience. The overall organisation is very good.
Servier
Zakia Felloussi, External Opportunities Director, R&D - France - December 2025
I thoroughly enjoyed the BD&L Course for Pharma & Biotech. The course was engaging and comprehensive, covering a wide range of essential topics in business development and licensing. It was enriched with practical case studies that brought real-world insights to the material. I highly recommend this course to anyone involved in BD&L activities, whether you are just starting your career or already have a solid background in the field and are looking to structure and deepen your existing knowledge.
JJP Biologics
Sandra Szydlowska, Head of Business Development - Poland - December 2025
This course is very helpful for understanding the basics of BD, including calculations and the environment of out- and in-licensing. It’s a great first step into the world of BD for someone less familiar with the field, and it helps participants decide where to further develop their skills (financials, negotiation, etc.). The case study provides an excellent summary of the two days.
Roche
Carole Mainguet, External Collaboration Lead - Switzerland - September 2025
Very nice overview of everything that is part of BD and Licensing! There is a variety of topics covered, and the teaching qualities of Carlos Velez were amazing. The organisation of the course was great.
Daiichi Sankyo Europe
Joris Komen, Senior Medical Manager New Products - The Netherlands - September 2025
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
Attending the 2-day Business Development and Licensing course was an incredibly enriching experience. The sessions were thoughtfully structured, and the quality of discussions was exceptional throughout. The facilitators created an engaging environment that encouraged active participation and real-world application.
3D Matrix Europe
Sharanya Sankar, R&D and Business Development Manager - France - June 2025
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The course covered a broad range of topics within the Business Development and Licensing world, making it highly valuable. Carlos is an eloquent speaker, and CELforPharma is helpful and supportive.
Tecnimede
Alexandre Sousa Coelho, Junior In-licensing and Business Development Manager - Portugal - March 2025
An outstanding course with excellent organisation and a very experienced teacher. Well worth attending to gain valuable insights into many aspects of Business Development & Licensing. Highly recommended, regardless of your level of experience.
Syva
Alfonso Martín-Fontecha, Business Development Technical Manager - Spain - March 2025
A great, hands-on Business Development course.
Gergely Vertes, Biotech Launch Lead - Rare Disease Expert - Belgium - March 2025
Very informative course for professionals entering the BD market. The trainer is obviously vastly experienced in this sector and managed to transfer a lot of knowledge to the participants.
Viatris
Zafeirios Anagnostopoulos, Senior Medical Manager Business Development - Europe - December 2024
It was a great course with good interaction! I have learned tools, specific terms, and some financial aspects. My company is more oriented on CPALs, ..., active ingredients, and not so much pills anymore, so I am a bit far from pre-clinicals and phases, but that was in the name of the course and still good to explore. Thank you!
Expanscience Laboratories
Sacha Marsollier, Business Development Project Manager - France - September 2024
Carlos Velez is a great speaker and very didactical!
Exeltis
Julia Redondo, Open Innovation Manager - Spain - June 2024
This course gave a complete overview of all BD aspects. Carlos' own experience, examples and practical tips really added to this learning experience and the tools & processes shared (e.g. pitch deck, follow up, etc.) were also valuable. Thank you very much for two engaging and insightful days!
Zealand Pharma
Dino Bertani, Vice President, Head of Alliance Management - Denmark - March 2024
Excellent course covering the fundamentals of in- and out-licensing for pharma and biotech. Highly recommended to anyone involved with licensing in biotech.
Debiopharm
Blaise Calpe, Evaluation Manager Oncology - Switzerland - March 2024
Very valuable course with great content, good speaker and great organisation.
Neuvasq
Isabel Vogel, Senior Scientist/Alliance Manager - Belgium - March 2024
I enjoyed this dynamic and comprehensive introduction to BD&L for Pharma and Biotech. I strongly recommend this course for anyone who is looking for an overview of the in- and out-licensing process.
Boehringer Ingelheim
Hervé Poulet, Strategic Partnerships Senior Director - France - November 2023
Carlos is a great speaker, sharing knowledge & experience in a dynamic and pleasant manner, even in a live online format.
Valneva
Henri Pierre, Global Brand Director - France - November 2023
The "Business Development & Licensing Course For Pharma & Biotech" has been an excellent opportunity for me to benchmark my technical skills with other relevant professionals, to get new insights on the topic and, at a glance, to improve the way I do my job and the value I can bring to the company.
Molteni Farma
Rodolfo Perriccioli, Business Development & Alliance Management - Italy - November 2023
Really interesting course with a valuable expert. The organisation by the CELforPharma team was very nice.
Horus Pharma
Camille Guerin, R&D Director & Interim Qualified Person - France - September 2023
For pharmaceutical executives who don't work directly in BD&L, this is probably the best course to learn the basics and much more in this field.
Daiichi Sankyo
Dan Ionescu, VP, Head of Value and Access Specialty Medicines EU - Germany - September 2023
Valuable course for BD&L professionals and people who want to understand this perspective of the industry.
Alkaloid
Viktorija Pavlovikj, Out Licensing Specialist - North Macedonia - September 2023
As a CELforPharma faculty member, Dr Carlos Velez regularly shares his practical knowledge and industry experience through articles, insights and webinars.
Browse a selection below that relates to the themes of this course:
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis or call +32 473 65 15 77.
Course Details
Dates & Locations
Special offer for biotech start-ups & academia: Apply for a € 400 discount. Contact Annelies Swaan for more details.
Upcoming Session
11-12 June 2026, Live online
Early bird € 2 670
(until 08/05/2026)
(Full fee € 2 870)
Prices are excl. VAT
THE CONTENT
For many pharma companies, business development (BD) is the most important source of new products. Yet, too often, BD efforts underperform due to a lack of strategic alignment and limited understanding across the organisation of how the full licensing process works.
This course provides a clear and practical overview of the BD&L process in the pharma-biotech industry. By connecting the dots between strategy, process, and execution, it equips you with the essential foundation to understand the full BD&L process – from sourcing and evaluating opportunities to valuation, term sheets, and the fundamentals of negotiation – all within the context of pharma-biotech business development.
If you want to build the skills and confidence to actively contribute to successful BD&L activities, this course is the perfect investment!
Very nice overview of everything that is part of BD and Licensing! There is a variety of topics covered, and the teaching qualities of Carlos Velez were amazing. The organisation of the course was great.
Daiichi Sankyo Europe
Joris Komen, Senior Medical Manager New Products - The Netherlands - September 2025
THE EXPERT
Dr Carlos Velez is a seasoned expert in pharma and biotech business development and licensing.
Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in in- and out-licensing of prescription and non-prescription product candidates and commercial products across multiple therapeutic areas and markets.
Over 10 years in senior business development roles at Penwest Pharmaceuticals, Lantic Therapeutics, Forest Labs, and Genencor (now Danisco).
Author of Partnering for Growth – Business Development and Licensing in Pharma and Biotech (2025), a comprehensive guide reflecting his extensive industry insights.
Highly experienced trainer and consultant who is consistently praised by participants for his excellent didactic approach and his ability to draw from his vast experience in business development and licensing.
To get a flavour of Carlos’ expertise and teaching style, watch this recent educational webinar:
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This introductory course is designed for:
Mid- to senior-level executives in pharma and biotech companies with limited formal training in BD&L but whose role increasingly involves licensing activities.
Junior- to mid-level managers contributing to the BD&L process in the headquarters of midsize and large pharma companies (e.g. technology assessment, business intelligence) who need a better understanding of the full licensing process in a business development context.
Managers in local marketing organisations with responsibility for business development and licensing in national markets will also benefit, but they should be aware that the course content is geared towards international BD&L responsibilities.
Executives working in generics companies should be aware that the content of this course concentrates on licensing deals involving branded pharmaceuticals.
This course is very helpful for understanding the basics of BD, including calculations and the environment of out- and in-licensing. It’s a great first step into the world of BD for someone less familiar with the field, and it helps participants decide where to further develop their skills (financials, negotiation, etc.). The case study provides an excellent summary of the two days.
Roche
Carole Mainguet, External Collaboration Lead - Switzerland - September 2025
The role of the BD&L function and partnering models for corporate growth.
Key success factors and tips for the planning and execution of both the in- and out-licensing process.
What you need to know about patents and intellectual property.
Overview of forecasting and valuation tools, methods and approaches.
Introduction to term sheets, negotiation, closing the deal and managing the alliance.
Where and how AI can be used along the BD&L process.
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
Day 1
| Welcome & Audience Expectations (~30 min) |
| Introduction to Business Development in Pharma/Biotech (~1 h) |
|
| Out-Licensing: Planning and Execution (~1 h) |
|
| Lunch Break |
| Workshop #1: AI-Assisted Out-Licensing (~45 min) |
|
| In-Licensing: Planning & Execution (~1 h 15 min) |
|
| Valuation of Drug Candidates – Part I (~1 h 45 min) |
|
Day 2
| Day One Questions and Comments (~15 min) |
| Patents and Intellectual Property (~45 min) |
|
| Valuation of Drug Candidates – Part II (~1 h 15 min) |
|
| Workshop #2: AI-Assisted In-Licensing (~45 min) |
|
| Lunch Break |
| Term Sheets and Contracts (~1 h) |
|
| Special Situations (~1 h) |
|
| Negotiation & Alliance Management (~45 min) |
|
| Workshop #3 – AI-Assisted Licensing (~1 h) |
|
| Q&A and Closing (~15 min) |
UPCOMING DATES & FORMATS - FEES
11-12 June 2026
Live online
Early bird € 2 670
(until 08/05/2026)
(Full fee € 2 870)
1-2 October 2026
Brussels
Early bird € 2 970
(until 14/08/2026)
(Full fee € 3 370)
10-11 December 2026
Live online
Early bird € 2 670
(until 06/11/2026)
(Full fee € 2 870)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
For live online courses:
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
For face-to-face courses:
Access to a highly interactive, small-group course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
Opportunities for networking and informal discussions during coffee/tea breaks and lunch
A group dinner in a nearby restaurant on the evening of day 1
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The Business Development & Licensing Course provided a valuable, structured approach to running BD tasks effectively. The exchange with participants from different backgrounds and with different interests enhanced the discussions and resulted in valuable takeaways for future daily assessment tasks. I also appreciated the overview of useful tools in this context and the perspective on AI. Many thanks, Carlos!
Daiichi Sankyo
Andrea Bilgeri, Director Market Access - Germany - March 2026
A great experience attending the Business Development & Licensing Course. It was a valuable opportunity to take a step back and reflect on how to approach BD activities in a more structured and strategic way. The exchange with professionals from different backgrounds made the discussions especially enriching and brought practical ideas to apply in our day-to-day work. Thank you, Carlos, for such an engaging course!
Medichem
Helena Huguet, Business Development Manager - Spain - March 2026
Dr Carlos Velez is a very good and experienced teacher who provides great examples and a clear structure for focusing on business development. I would highly recommend this course!
LTS Lohmann Therapie-Systeme
Christine Lohmann, Business Development Europe - Germany - March 2026
If you are interested in discovering or learning more about licensing, I recommend attending the CELforPharma Business Development & Licensing Course. It is led by an experienced and pragmatic trainer in a relaxed and interactive atmosphere.
OXB
Alain Rachon, Senior Director Business Development & Licensing - France - March 2026
Great course with a clear overview of the business development and licensing process. Recommended if you need to learn the basics.
Chiesi
Giorgia Iegiani, Competitive Intelligence Specialist - Italy - March 2026
A very helpful course for taking your first steps into BD. Carlos is an expert in the field and shares great tips and tricks.
Etherna Immunotherapies
Bram Bogaert, Business Development Manager - Belgium - March 2026
A very good training to get an overall overview of BD & Licensing. The trainer is highly skilled and clear in their explanations, and brings substantial practical experience. The overall organisation is very good.
Servier
Zakia Felloussi, External Opportunities Director, R&D - France - December 2025
I thoroughly enjoyed the BD&L Course for Pharma & Biotech. The course was engaging and comprehensive, covering a wide range of essential topics in business development and licensing. It was enriched with practical case studies that brought real-world insights to the material. I highly recommend this course to anyone involved in BD&L activities, whether you are just starting your career or already have a solid background in the field and are looking to structure and deepen your existing knowledge.
JJP Biologics
Sandra Szydlowska, Head of Business Development - Poland - December 2025
This course is very helpful for understanding the basics of BD, including calculations and the environment of out- and in-licensing. It’s a great first step into the world of BD for someone less familiar with the field, and it helps participants decide where to further develop their skills (financials, negotiation, etc.). The case study provides an excellent summary of the two days.
Roche
Carole Mainguet, External Collaboration Lead - Switzerland - September 2025
Very nice overview of everything that is part of BD and Licensing! There is a variety of topics covered, and the teaching qualities of Carlos Velez were amazing. The organisation of the course was great.
Daiichi Sankyo Europe
Joris Komen, Senior Medical Manager New Products - The Netherlands - September 2025
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
Attending the 2-day Business Development and Licensing course was an incredibly enriching experience. The sessions were thoughtfully structured, and the quality of discussions was exceptional throughout. The facilitators created an engaging environment that encouraged active participation and real-world application.
3D Matrix Europe
Sharanya Sankar, R&D and Business Development Manager - France - June 2025
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The course covered a broad range of topics within the Business Development and Licensing world, making it highly valuable. Carlos is an eloquent speaker, and CELforPharma is helpful and supportive.
Tecnimede
Alexandre Sousa Coelho, Junior In-licensing and Business Development Manager - Portugal - March 2025
An outstanding course with excellent organisation and a very experienced teacher. Well worth attending to gain valuable insights into many aspects of Business Development & Licensing. Highly recommended, regardless of your level of experience.
Syva
Alfonso Martín-Fontecha, Business Development Technical Manager - Spain - March 2025
A great, hands-on Business Development course.
Gergely Vertes, Biotech Launch Lead - Rare Disease Expert - Belgium - March 2025
Very informative course for professionals entering the BD market. The trainer is obviously vastly experienced in this sector and managed to transfer a lot of knowledge to the participants.
Viatris
Zafeirios Anagnostopoulos, Senior Medical Manager Business Development - Europe - December 2024
It was a great course with good interaction! I have learned tools, specific terms, and some financial aspects. My company is more oriented on CPALs, ..., active ingredients, and not so much pills anymore, so I am a bit far from pre-clinicals and phases, but that was in the name of the course and still good to explore. Thank you!
Expanscience Laboratories
Sacha Marsollier, Business Development Project Manager - France - September 2024
Carlos Velez is a great speaker and very didactical!
Exeltis
Julia Redondo, Open Innovation Manager - Spain - June 2024
This course gave a complete overview of all BD aspects. Carlos' own experience, examples and practical tips really added to this learning experience and the tools & processes shared (e.g. pitch deck, follow up, etc.) were also valuable. Thank you very much for two engaging and insightful days!
Zealand Pharma
Dino Bertani, Vice President, Head of Alliance Management - Denmark - March 2024
Excellent course covering the fundamentals of in- and out-licensing for pharma and biotech. Highly recommended to anyone involved with licensing in biotech.
Debiopharm
Blaise Calpe, Evaluation Manager Oncology - Switzerland - March 2024
Very valuable course with great content, good speaker and great organisation.
Neuvasq
Isabel Vogel, Senior Scientist/Alliance Manager - Belgium - March 2024
I enjoyed this dynamic and comprehensive introduction to BD&L for Pharma and Biotech. I strongly recommend this course for anyone who is looking for an overview of the in- and out-licensing process.
Boehringer Ingelheim
Hervé Poulet, Strategic Partnerships Senior Director - France - November 2023
Carlos is a great speaker, sharing knowledge & experience in a dynamic and pleasant manner, even in a live online format.
Valneva
Henri Pierre, Global Brand Director - France - November 2023
The "Business Development & Licensing Course For Pharma & Biotech" has been an excellent opportunity for me to benchmark my technical skills with other relevant professionals, to get new insights on the topic and, at a glance, to improve the way I do my job and the value I can bring to the company.
Molteni Farma
Rodolfo Perriccioli, Business Development & Alliance Management - Italy - November 2023
Really interesting course with a valuable expert. The organisation by the CELforPharma team was very nice.
Horus Pharma
Camille Guerin, R&D Director & Interim Qualified Person - France - September 2023
For pharmaceutical executives who don't work directly in BD&L, this is probably the best course to learn the basics and much more in this field.
Daiichi Sankyo
Dan Ionescu, VP, Head of Value and Access Specialty Medicines EU - Germany - September 2023
Valuable course for BD&L professionals and people who want to understand this perspective of the industry.
Alkaloid
Viktorija Pavlovikj, Out Licensing Specialist - North Macedonia - September 2023
As a CELforPharma faculty member, Dr Carlos Velez regularly shares his practical knowledge and industry experience through articles, insights and webinars.
Browse a selection below that relates to the themes of this course:
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis or call +32 473 65 15 77.